FOR IMMEDIATE RELEASE First MDMA-Assisted Therapy for PTSD Approved in Manitoba A major step forward for access to mental health treatment in the province. WINNIPEG, MB, February 18, 2026 — In a landmark development for mental health care in the Prairies, the Enhanced Therapy Institute (ETI) has secured Manitoba’s first … Read more
FOR IMMEDIATE RELEASE World’s First Wellness-Focused Psychedelic Therapy Trial Launches in Canada Community-funded study will evaluate whether therapist-guided psychedelic therapy can enhance everyday wellness Victoria, BC, October 15, 2025 — A coalition of Canadian researchers, clinicians, and nonprofit advocates has received Health Canada authorization to launch PsilWell, the first clinical study … Read more
FOR IMMEDIATE RELEASE Federal Court of Appeal Rules in Favour of TheraPsil and 96 Healthcare Professionals in Landmark Psilocybin Training Case Court finds Health Minister’s reversal “unreasonable,” reigniting national focus on psychedelic therapy OTTAWA, ON – June 20, 2025 – In a decisive victory for healthcare professionals and psychedelic therapy access, the Federal Court … Read more
FOR IMMEDIATE RELEASE TheraPsil Introduces Beta Online Psilocybin Therapy Training for 2025 VANCOUVER, BC, December 3, 2024 — TheraPsil is proud to announce the launch of its beta online Fundamentals of Psilocybin-Assisted Therapy training program, beginning in January 2025. Designed as a pilot version, this new offering provides a flexible, accessible way for healthcare … Read more
FOR IMMEDIATE RELEASE TheraPsil Launches Canada’s Largest Psychedelic Therapy Directory Psychedelic network connects patients with trained psychedelic practitioners across Canada VANCOUVER, BC, August 6, 2024 – TheraPsil, a non-profit advocacy and training organization dedicated to advancing legal access to psychedelics in Canada, has launched the “Psychedelic Therapy Directory”, Canada’s most extensive network for psychedelic … Read more
FOR IMMEDIATE RELEASE TheraPsil Welcomes Dr. Ingrid Pacey as Clinical Director to Expand Psychedelic Therapy Training Programs VANCOUVER, BC, June 27, 2024 – TheraPsil is pleased to announce that Dr. Ingrid Pacey has been named its new Clinical Director, where she will oversee all of TheraPsil’s training programs. With a rich history in … Read more
FOR IMMEDIATE RELEASE First Canadian Patient with Cluster Headaches Granted Psilocybin Access by Health Canada Historic decision marks a new chapter in compassionate healthcare June 12, 2024 – Ottawa, ON – Health Canada has taken a historic step by granting emergency access to psilocybin for Jody Lance, a Calgary man suffering from debilitating … Read more
FOR IMMEDIATE RELEASE Breakthrough for Medical Psilocybin: Court Overturns Health Canada Decision Federal Court Deems Health Canada’s Decision “Unreasonable” and “Lacking Intelligibility” Ottawa, Ontario, May 24, 2024 – TheraPsil, a non-profit coalition dedicated to helping Canadians in medical need access legal psychedelic therapy, is celebrating a significant landmark decision by the Federal Court of … Read more
FOR IMMEDIATE RELEASE Quebec Breaks New Ground in Psychedelic Therapy: Patients Treated Together at Hope & Cope Cancer Wellness Centre MONTRÉAL, QC, November 13th, 2023 – In a historic development, two cancer patients received simultaneous psilocybin-assisted therapy (PAT) treatment on September 22nd, 2023, at The Hope & Cope Wellness Centre in Montréal, under the care of … Read more
FOR IMMEDIATE RELEASE TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program VANCOUVER, BC, September 25th, 2023 – TheraPsil, an non-profit organization dedicated to advancing legal access to psychedelic-assisted psychotherapy in Canada, is pleased to announce its latest endeavour, which has just received Board approval: an MDMA-Assisted Psychotherapy Training Program. With over 500 healthcare professionals trained in … Read more
TheraPsil is thrilled to announce a major undertaking: our team is embarking on a groundbreaking clinical trial that is set to make waves. Our ultimate goal for this trial is to establish a viable pathway for practitioners undergoing psilocybin-assisted psychotherapy training, as well as patients in medical need, to access this transformative therapy. Due to … Read more
VANCOUVER, BC, May 9th, 2023, Lucy Scientific, a clinical-stage natural and synthetic psychedelic drug development company, has officially announced its participation in TheraPsil’s Project Solace, the world’s largest medical psilocybin access and data project. Project Solace is a TheraPsil-led research project that aims to expand legal access to psilocybin for Canadian patients suffering from end-of-life … Read more
Dear Ministers Jean Yves Duclos and Minister Carolyn Bennett, I am writing on behalf of TheraPsil, a non-profit organization that advocates for access to psilocybin-assisted psychotherapy for Canadians in medical need. We urge you to reconsider the recent decisions to revoke Section 56 exemptions for Janis Hughes and Thomas Hartle, two terminally ill Canadians who … Read more
Vancouver, BC – TheraPsil, a non-profit and training organization dedicated to legalizing access to psilocybin therapy for patients in medical need, expresses grave concern over recent allegations of Health Minister Jean-Yves Duclos interfering with the work of the Patented Medicine Prices Review Board (PMPRB), which has been engaged in a multi-year effort to implement changes … Read more
(Montreal, QC – April 13th, 2023) – TheraPsil, a non-profit organization dedicated to promoting legal access to psilocybin-assisted psychotherapy in Canada, is pleased to announce its very first bilingual training cohort for the Fundamentals of Psilocybin Assisted Psychotherapy program. This training program is designed to provide participants with the necessary knowledge and skills to offer … Read more
TheraPsil Applauds Healthcare Funding to B.C. From Federal Government VANCOUVER, BC (March 6th, 2023) – TheraPsil, a Vancouver-based non-profit and training organization advocating for legal access to psilocybin for those in medical need, welcomes the recent healthcare funding agreement between the British Columbia (B.C.) government and the federal government. TheraPsil is thrilled to be … Read more
Special Joint Committee on Medical Assistance in Dying Recommends Review of Psilocybin for Palliative Care & Research A Canadian parliamentary committee has made 23 recommendations to improve the country’s assisted-dying regime. Among the recommendations is a call for Health Canada to review the potential use of psilocybin as a therapy for both research purposes and … Read more
Poll shows 80% of Canadians believe psilocybin mushrooms should be legal for medical purposes Victoria, BC (January 24rd, 2023) – TheraPsil, a non-profit coalition based in Victoria, BC, recently conducted a poll in collaboration with Pollara to gauge public opinion on the legalization of psilocybin (the psychoactive component of “magic” mushrooms) for medical use … Read more
To: The Honourable Minister of Health, Jean-Yves Duclos and The Honourable Minister of Mental Health and Addictions, Dr. Carolyn Bennett House of Commons, Ottawa, Ontario, Canada K1A 0A6 From: Thomas Hartle, Janis Hughes, James Doswell, Bruce Tobin, Jesse Merks, Jane Harrison, Shannon McKenney RE: REQUEST TO END LEGAL INITIATIVE FOR MEDICAL PSILOCYBIN ACCESS … Read more
Patients and Medical Professionals to Return to Ottawa in February to Defend their Right to Medical Psilocybin Seeking compassionate access to psilocybin as a treatment for Canadians suffering from chronic disease, addiction and palliative depression and as a supplemental and/or alternative treatment to Medical Assistance in Dying (MAiD) Victoria, BC (January 11, 2022) – TheraPsil … Read more
